Koyfin Home > Directory > Health Care > LA Jolla Pharma > Net Debt / EBITDA

LA Jolla Pharma Net Debt / EBITDA Chart (LJPC)

LA Jolla Pharma annual/quarterly Net Debt / EBITDA from 2010 to 2020. Net Debt / EBITDA is a measure of leverage for a company by dividing the Debt less Cash on hand vs. EBITDA.
  • LA Jolla Pharma Net Debt / EBITDA for the quarter ending June 06, 2020 was $-3m a 81.04% decrease of -2m year over year
  • LA Jolla Pharma Net Debt / EBITDA for the last 12 months ending June 06, 2020 was $-1m a 67.72% decrease of -1m year over year
  • LA Jolla Pharma Annual Net Debt / EBITDA for 2019 was $-1m a 136.68% decrease of -1m from 2018
  • LA Jolla Pharma Annual Net Debt / EBITDA for 2018 was $0m a -206.22% decrease of -1m from 2017
  • LA Jolla Pharma Annual Net Debt / EBITDA for 2017 was $1m a -6.30% decrease of 0m from 2016
Other Ratios Metrics:
  • LA Jolla Pharma Total Debt / Capital for the quarter ending September 09, 2018 was $62m a 91.86% increase of 57m year over year
  • LA Jolla Pharma Other Liabilities for the quarter ending December 12, 2018 was $14m a 1.00% increase of 0m year over year
  • LA Jolla Pharma Total Debt / Equity for the quarter ending September 09, 2018 was $166m a 96.77% increase of 160m year over year
View Chart On Koyfin

Quarterly LJPC Net Debt / EBITDA Data

06/2020$-3m
03/2020$-2m
12/2019$-1m
09/2019$0m
06/2019$0m
03/2019$0m
12/2018$0m
09/2018$0m
06/2018$1m
03/2018$1m

Annual LJPC Net Debt / EBITDA Data

2019$-1m
2018$0m
2017$1m
2016$1m
2015$3m
2014$2m
2013$0m
2010$2m